LONDON and SINGAPORE - CME Group, the world's leading derivatives marketplace, reported a significant increase in its international trading activity for 2023, with average daily volume (ADV) outside the United States reaching a new high of 6.8 million contracts. This marks an 8% rise from the previous year, attributed mainly to robust growth in Equity Index and Interest Rate products, which surged 26% and 23% respectively.
The record-setting performance was particularly pronounced in the Europe, Middle East, and Africa (EMEA) region, where ADV soared to 4.9 million contracts, a 13% jump from 2022. This growth was fueled by a notable 29% uptick in Interest Rate products and a 26% advance in Agricultural products.
In Latin America, trading volumes also reached new heights, with ADV climbing to 176,000 contracts, up 11% from the previous year. Growth was led by a 28% increase in Foreign Exchange products, a 27% rise in Interest Rate products, and a 24% expansion in Metals products.
Asia Pacific saw its ADV hit 1.6 million contracts with Interest Rate products achieving a 5% year-on-year increase, culminating in a record of 689,000 contracts in 2023. Meanwhile, Canada's ADV totaled 153,000 contracts, with Energy and Agricultural Products experiencing gains of 22% and 7% respectively.
On a global scale, CME Group's (NASDAQ:CME) overall ADV reached a new peak of 24.4 million contracts in 2023, up 5% over the prior year. This global growth was largely propelled by a 16% rise in Interest Rate ADV, which hit a record 12.5 million contracts, and a 23% surge in Options ADV, reaching a new high of 5.1 million contracts.
CME Group's extensive product offerings include a wide range of benchmark futures and options across various asset classes, such as interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company operates major trading platforms like the CME Globex platform and offers services through central counterparty clearing provider, CME Clearing.
This announcement, based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.